News Article

Dr Leonid Shapiro, Managing Partner at Candesic, shares insights with Healthcare Business International on Fremman Capital’s acquisition of Amethyst Healthcare Group and what it signals for Europe’s radiotherapy sector.

He highlights growing consolidation in a fragmented market and how new reimbursement models are reshaping incentives and driving efficiency. As investor interest climbs, radiotherapy is becoming a key focus for private equity and infrastructure funds.